Omnicell Company Profile (NASDAQ:OMCL)

About Omnicell

Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment organizes the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. Its product line includes OmniRx, SinglePointe, AnywhereRN, Omnicell and Pandora Data Analytics, Savvy Mobile Medication System, Central Pharmacy and Satellite Pharmacy Manager, Anesthesia Workstation and Advanced Interoperability products.

Industry, Sector and Symbol:

Sector: Medical
Industry: Healthcare Information Services
Sub-Industry: Health Care Technology
Exchange: NASDAQ
Symbol: OMCL
CUSIP: 68213N10

Key Metrics:

Previous Close: $38.10
50 Day Moving Average: $37.83
200 Day Moving Average: $33.47
52-Week Range: $25.06 - $40.50
Trailing P/E Ratio: 96.70
Foreward P/E Ratio: 20.16
P/E Growth: 1.44
Market Cap: $1.38B
Outstanding Shares: 36,161,000
Beta: 0.69

Profitability:

Net Margins: 2.36%
Return on Equity: 10.41%
Return on Assets: 5.63%

Debt:

Debt-to-Equity Ratio: 0.53%
Current Ratio: 1.63%
Quick Ratio: 1.25%

Additional Links:

Companies Related to Omnicell:

Consensus Ratings for Omnicell (NASDAQ:OMCL) (?)

Ratings Breakdown:	2 Hold Ratings, 5 Buy Ratings
Consensus Rating:	Buy (Score: 2.71)
Consensus Price Target:	$37.71 (1.01% downside)

Analysts' Ratings History for Omnicell (NASDAQ:OMCL)

Show:

Date	Firm	Action	Rating	Price Target
9/13/2016	Oppenheimer Holdings Inc.	Reiterated Rating	Outperform	$46.00
9/8/2016	Sidoti	Downgrade	Buy -> Neutral	$43.00
7/29/2016	FBR & Co	Boost Price Target	Outperform	$40.00 -> $41.00
3/21/2016	Topeka Capital Markets	Lower Price Target	Buy	$38.00 -> $37.00
2/5/2016	Piper Jaffray Cos.	Lower Price Target	Overweight	$42.00 -> $35.00
1/7/2016	Benchmark Co.	Initiated Coverage	Buy	$33.00
11/1/2015	Cowen and Company	Reiterated Rating	Market Perform	$37.00 -> $29.00
6/18/2015	Stephens	Initiated Coverage	Outperform	$44.00
5/9/2015	Craig Hallum	Reiterated Rating	Buy	$42.00

(Data available from 9/28/2014 forward)

Earnings History for Omnicell (NASDAQ:OMCL)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/27/2016
7/28/2016	Q216	$0.32	$0.38	$170.89 million	$175.60 million	View	Listen
4/28/2016	Q116	$0.26	$0.35	$167.18 million	$171.00 million	View	Listen
2/4/2016	Q415	$0.39	$0.40	$126.89 million	$130.30 million	View	Listen
10/29/2015	Q315	$0.36	$0.36	$128.50 million	$125.20 million	View	Listen
7/30/2015	Q215	$0.32	$0.28	$121.35 million	$112.80 million	View	Listen
4/30/2015	Q115	$0.23	$0.29	$112.00 million	$16.20 million	View	N/A
2/3/2015	Q414	$0.33	$0.39	$114.65 million	$121.50 million	View	Listen
10/30/2014	Q314	$0.31	$0.30	$106.10 million	$112.50 million	View	Listen
7/31/2014	Q214	$0.29	$0.30	$103.23 million	$105.10 million	View	Listen
5/1/2014	Q114	$0.24	$0.26	$97.49 million	$101.80 million	View	Listen
2/4/2014	Q413	$0.28	$0.29	$101.13 million	$105.80 million	View	Listen
10/31/2013	Q313	$0.28	$0.31	$94.96 million	$94.03 million	View	N/A
8/1/2013	Q2 2013	$0.25	$0.27	$92.42 million	$93.70 million	View	N/A
5/2/2013	Q1 2013	$0.19	$0.21	$87.20 million	$87.11 million	View	N/A
1/31/2013	Q4 2012	$0.25	$0.25	$87.31 million	$90.16 million	View	N/A
10/25/2012		$0.22	$0.29			View	N/A
8/1/2012		$0.18	$0.20			View	N/A
5/2/2012		$0.13	$0.13			View	N/A
1/26/2012		$0.16	$0.19			View	N/A
10/27/2011		$0.16	$0.16			View	N/A
7/28/2011		$0.13	$0.15			View	N/A
5/2/2011		$0.10	$0.11			View	N/A
1/27/2011		$0.12	$0.11			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Omnicell (NASDAQ:OMCL)

Current Year EPS Consensus Estimate: $1.58 EPS
Next Year EPS Consensus Estimate: $1.89 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	$0.24	$0.24	$0.24
Q2 2016	1	$0.21	$0.21	$0.21
Q3 2016	1	$0.31	$0.31	$0.31
Q4 2016	1	$0.38	$0.38	$0.38

(Data provided by Zacks Investment Research)

Dividend History for Omnicell (NASDAQ:OMCL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Omnicell (NASDAQ:OMCL)

Insider Ownership Percentage: 3.75%
Institutional Ownership Percentage: 95.26%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/12/2016	Gary S Petersmeyer	Director	Sell	2,000	$37.98	$75,960.00
9/8/2016	Gary S Petersmeyer	Director	Sell	2,400	$39.39	$94,536.00
9/6/2016	Gary S Petersmeyer	Director	Sell	2,000	$39.02	$78,040.00
9/2/2016	Gary S Petersmeyer	Director	Sell	3,000	$38.52	$115,560.00
8/19/2016	Dan S Johnston	EVP	Sell	8,850	$36.93	$326,830.50
8/19/2016	Jorge R Taborga	VP	Sell	1,778	$36.92	$65,643.76
8/11/2016	Randall A Lipps	Chairman	Sell	37,425	$37.37	$1,398,572.25
8/9/2016	J Christopher Drew	VP	Sell	15,000	$37.89	$568,350.00
8/9/2016	James T Judson	Director	Sell	6,250	$37.98	$237,375.00
8/4/2016	Gary S Petersmeyer	Director	Sell	8,750	$37.84	$331,100.00
7/29/2016	Jorge R Taborga	VP	Sell	10,023	$40.00	$400,920.00
7/6/2016	Robin Gene Seim	EVP	Sell	5,302	$34.75	$184,244.50
7/1/2016	Robin Gene Seim	EVP	Sell	3,645	$35.00	$127,575.00
6/6/2016	Jorge R Taborga	VP	Sell	25,979	$33.00	$857,307.00
5/24/2016	Gary S Petersmeyer	Director	Sell	6,250	$31.22	$195,125.00
5/20/2016	Dan S Johnston	EVP	Sell	8,850	$30.73	$271,960.50
5/20/2016	Jorge R Taborga	VP	Sell	1,933	$30.73	$59,401.09
5/10/2016	J Christopher Drew	VP	Sell	15,000	$31.63	$474,450.00
5/5/2016	Sara J White	Director	Sell	2,000	$31.76	$63,520.00
4/29/2016	Robin Gene Seim	EVP	Sell	6,407	$31.00	$198,617.00
4/26/2016	Jorge R Taborga	VP	Sell	23,827	$30.00	$714,810.00
4/26/2016	Robin Gene Seim	EVP	Sell	767	$30.00	$23,010.00
2/19/2016	Dan S Johnston	EVP	Sell	8,850	$27.41	$242,578.50
2/19/2016	Jorge R Taborga	VP	Sell	1,685	$27.42	$46,202.70
2/11/2016	Randall A. Lipps	CEO	Sell	40,000	$27.81	$1,112,400.00
2/9/2016	J Christopher Drew	VP	Sell	15,000	$27.57	$413,550.00
12/18/2015	Nhat H. Ngo	VP	Sell	4,069	$28.71	$116,820.99
11/17/2015	Dan S. Johnston	VP	Sell	2,500	$28.00	$70,000.00
11/10/2015	J Christopher Drew	VP	Sell	25,000	$26.79	$669,750.00
11/9/2015	Dan S. Johnston	VP	Sell	2,700	$27.29	$73,683.00
10/13/2015	Gary S. Petersmeyer	Director	Sell	670	$31.66	$21,212.20
8/13/2015	Robin Gene Seim	CFO	Sell	23,946	$35.63	$853,195.98
7/1/2015	Robin Gene Seim	CFO	Sell	19,582	$37.84	$740,982.88
6/17/2015	Nhat H Ngo	VP	Sell	4,067	$38.78	$157,718.26
6/2/2015	James T Judson	Director	Sell	8,032	$36.83	$295,818.56
6/2/2015	Nhat H Ngo	VP	Sell	6,375	$36.80	$234,600.00
5/26/2015	Sara J White	Director	Sell	4,000	$36.25	$145,000.00
5/7/2015	Dan S Johnston	VP	Sell	7,715	$34.25	$264,238.75
2/12/2015	J Christopher Drew	VP	Sell	25,000	$34.62	$865,500.00
2/6/2015	Dan S Johnston	VP	Sell	6,552	$33.29	$218,116.08
2/2/2015	James T Judson	Director	Sell	5,000	$31.61	$158,050.00
1/13/2015	Gary S Petersmeyer	Director	Sell	670	$31.31	$20,977.70
1/2/2015	James T Judson	Director	Sell	5,000	$32.36	$161,800.00
1/2/2015	Robin Gene Seim	CFO	Sell	1,948	$32.36	$63,037.28
12/17/2014	Marga Ortigas-Wedekind	VP	Sell	4,080	$32.20	$131,376.00
12/15/2014	Gary S Petersmeyer	Director	Sell	670	$33.25	$22,277.50
12/8/2014	Nhat H Ngo	VP	Sell	1,754	$32.89	$57,689.06
12/1/2014	James T Judson	Director	Sell	5,000	$31.94	$159,700.00
11/12/2014	Randy D Lindholm	Director	Sell	5,000	$31.72	$158,600.00
11/11/2014	J Christopher Drew	VP	Sell	37,500	$31.86	$1,194,750.00
11/7/2014	Dan S Johnston	VP	Sell	27,625	$31.74	$876,817.50
11/3/2014	James T Judson	Director	Sell	5,000	$32.27	$161,350.00
10/3/2014	Nhat H Ngo	VP	Sell	2,275	$28.00	$63,700.00
10/1/2014	James T Judson	Director	Sell	5,000	$27.02	$135,100.00
9/15/2014	Jorge R Taborga	VP	Sell	944	$26.37	$24,893.28
9/15/2014	Robin Gene Seim	CFO	Sell	9,347	$26.32	$246,013.04
9/2/2014	James T Judson	Director	Sell	5,000	$28.18	$140,900.00
9/2/2014	Robin Gene Seim	CFO	Sell	27,500	$28.19	$775,225.00
8/26/2014	Dan S Johnston	VP	Sell	6,250	$28.00	$175,000.00
8/26/2014	James T Judson	Director	Sell	9,913	$27.91	$276,671.83
7/9/2014	Robin Gene Seim	CFO	Sell	2,442	$28.21	$68,888.82
7/1/2014	James T Judson	Director	Sell	5,000	$29.28	$146,400.00
6/26/2014	Marga Ortigas-Wedekind	VP	Sell	2,961	$28.17	$83,411.37
6/25/2014	Nhat H Ngo	VP	Sell	2,274	$28.00	$63,672.00
6/17/2014	Nhat H Ngo	VP	Sell	1,420	$27.70	$39,334.00
6/10/2014	Nhat H Ngo	VP	Sell	1,964	$26.38	$51,810.32
6/2/2014	Gary S Petersmeyer	Director	Sell	5,000	$26.45	$132,250.00
5/21/2014	Gary Petersmeyer	Director	Sell	2,000	$26.51	$53,020.00
5/13/2014	J Christopher Drew	VP	Sell	37,500	$26.08	$978,000.00
5/7/2014	Dan Johnston	VP	Sell	4,000	$25.25	$101,000.00
5/1/2014	James Judson	Director	Sell	5,000	$26.24	$131,200.00
4/8/2014	Nhat Ngo	VP	Sell	1,002	$27.40	$27,454.80
3/18/2014	Marga Ortigas-Wedekind	VP	Sell	5,880	$30.00	$176,400.00
3/18/2014	Randall Lipps	CEO	Sell	124,910	$29.89	$3,733,559.90
12/18/2013	Nhat Ngo	VP	Sell	1,462	$24.43	$35,716.66
12/18/2013	Randall Lipps	CEO	Sell	64,739	$24.30	$1,573,157.70
12/3/2013	Dan Johnston	VP	Sell	73,419	$23.24	$1,706,257.56
11/11/2013	Randy Lindholm	Director	Sell	3,587	$23.00	$82,501.00
11/7/2013	Dan Johnston	VP	Sell	8,000	$22.99	$183,920.00
10/23/2013	Robin Gene Seim	CFO	Sell	7,664	$24.50	$187,768.00
10/21/2013	Robin Gene Seim	CFO	Sell	9,349	$23.76	$222,132.24
10/1/2013	James T Judson	Director	Sell	5,000	$23.66	$118,300.00
9/24/2013	Randall Lipps	CEO	Sell	68,204	$25.00	$1,705,100.00
9/23/2013	Marga Ortigas-Wedekind	VP	Sell	4,000	$25.00	$100,000.00
9/23/2013	Randall Lipps	CEO	Sell	5,083	$25.00	$127,075.00
9/20/2013	Robin Gene Seim	CFO	Sell	27,500	$24.35	$669,625.00
9/18/2013	Randall Lipps	CEO	Sell	64,453	$23.67	$1,525,602.51
9/4/2013	Nhat H Ngo	VP	Sell	7,362	$24.00	$176,688.00
9/3/2013	James Judson	Director	Sell	5,000	$22.77	$113,850.00
8/20/2013	James Judson	Director	Sell	11,724	$22.74	$266,603.76
8/13/2013	J Christopher Drew	VP	Sell	20,000	$22.83	$456,600.00
8/12/2013	Donald Wegmiller	Director	Sell	34,976	$22.87	$799,901.12
8/7/2013	Dan Johnston	VP	Sell	8,000	$22.92	$183,360.00
8/6/2013	Randall Lipps	CEO	Sell	5,321	$23.00	$122,383.00
8/2/2013	Randall A Lipps	CEO	Sell	25,000	$22.50	$562,500.00
8/1/2013	James Judson	Director	Sell	5,000	$21.00	$105,000.00
7/19/2013	Nhat H Ngo	VP	Sell	41,875	$21.00	$879,375.00
7/19/2013	Randall A Lipps	CEO	Sell	5,080	$21.00	$106,680.00
7/1/2013	James T Judson	Director	Sell	5,000	$20.46	$102,300.00
7/1/2013	Robin Gene Seim	CFO	Sell	13,032	$20.42	$266,113.44
6/28/2013	Marga Ortigas-Wedekind	VP	Sell	4,545	$20.00	$90,900.00
6/28/2013	Randall A Lipps	CEO	Sell	25,000	$20.00	$500,000.00
6/21/2013	Nhat H Ngo	VP	Sell	3,459	$19.01	$65,755.59
6/18/2013	Randall A Lipps	CEO	Sell	66,378	$19.10	$1,267,819.80
6/10/2013	Randy D Lindholm	Director	Sell	23,901	$19.14	$457,465.14
6/4/2013	Robin Gene Seim	CFO	Sell	25,000	$18.72	$468,000.00
5/22/2013	Gary S Petersmeyer	Director	Sell	2,750	$18.10	$49,775.00
5/16/2013	J Christopher Drew	VP	Sell	26,000	$18.69	$485,940.00
5/14/2013	J Christopher Drew	VP	Sell	26,000	$18.45	$479,700.00
5/10/2013	Sara J White	Director	Sell	7,200	$18.50	$133,200.00
5/7/2013	Dan S Johnston	VP	Sell	8,000	$18.44	$147,520.00
12/3/2012	Gary S Petersmeyer	Director	Sell	1,359	$15.17	$20,616.03

(Data available from 1/1/2013 forward)

Latest Headlines for Omnicell (NASDAQ:OMCL)

Date	Headline
	Can Shares Of Omnicell, Inc. (NASDAQ:OMCL) Hit $46? - Investor Newswire (NASDAQ:OMCL) www.investornewswire.com - September 28 at 11:38 AM
	34.2% Return Seen to Date on SmarTrend Omnicell Call (OMCL) (NASDAQ:OMCL) www.mysmartrend.com - September 22 at 6:15 PM
	Omnicell Has Returned 31.9% Since SmarTrend Recommendation (OMCL) (NASDAQ:OMCL) www.mysmartrend.com - September 15 at 10:04 AM
	New Market Report: Sasa Polyester Sanayi A.S. (SASA) - Financial and Strategic SWOT Analysis Review (NASDAQ:OMCL) reports.pr-inside.com - September 12 at 6:17 PM
	Ratings Watch - Omnicell, Inc. (NASDAQ:OMCL) - Investor Newswire - Investor Newswire (NASDAQ:OMCL) www.investornewswire.com - September 12 at 11:10 AM
	Earnings According to Analysts for Omnicell, Inc. (NASDAQ:OMCL)? - Frisco Fastball (NASDAQ:OMCL) friscofastball.com - September 9 at 6:14 PM
	Shares Slipping Lower Over the Past Month: Omnicell, Inc. (NASDAQ:OMCL) - Post News (NASDAQ:OMCL) www.kentuckypostnews.com - September 1 at 6:35 PM
	ETF’s with exposure to Omnicell, Inc. : August 31, 2016 (NASDAQ:OMCL) www.capitalcube.com - September 1 at 9:45 AM
	Vermillion, Inc. (Nasdaq: VRML) to Ring The Nasdaq Stock Market Closing Bell (NASDAQ:OMCL) www.4-traders.com - August 31 at 11:39 AM
	Shares of OMCL Up 32.8% Since Uptrend Call on Shares (NASDAQ:OMCL) www.mysmartrend.com - August 31 at 11:39 AM
	Omnicell, Inc. (Nasdaq: OMCL) to Ring The Nasdaq Stock Market Opening Bell - GlobeNewswire (press release) (NASDAQ:OMCL) www.globenewswire.com - August 29 at 11:07 AM
	Shares of OMCL Up 31.7% Since Uptrend Call on Shares (NASDAQ:OMCL) www.mysmartrend.com - August 23 at 6:47 PM
	Will Omnicell, Inc. (NASDAQ:OMCL) Hit $46 Price Target? - Investor Newswire (NASDAQ:OMCL) www.investornewswire.com - August 18 at 9:41 AM
	OMNICELL, INC Financials (NASDAQ:OMCL) finance.yahoo.com - August 16 at 6:46 PM
	32.1% Return Seen to Date on SmarTrend Omnicell Call (OMCL) (NASDAQ:OMCL) www.mysmartrend.com - August 16 at 9:53 AM
	Omnicell, Inc. (NASDAQ:OMCL) Brokerage Rating Update - Investor Newswire (NASDAQ:OMCL) www.investornewswire.com - August 11 at 9:51 AM
	Omnicell Stock Sees Short Interest Decrease By 20.2% (NASDAQ:OMCL) www.marketnewsvideo.com - August 10 at 7:04 PM
	Tygh Capital Management, Inc. Adjusts Its Holdings in Omnicell, Inc ... - Finance Daily (NASDAQ:OMCL) www.fidaily.com - August 5 at 6:49 PM
	Omnicell, Inc. (NASDAQ:OMCL) Trading Up - Insiders Selling, Short Interest Growing - Finance Daily (NASDAQ:OMCL) www.fidaily.com - August 5 at 6:49 PM
	OMNICELL, INC Files SEC form 8-K, Other Events (NASDAQ:OMCL) biz.yahoo.com - August 5 at 6:49 PM
	Omnicell, Inc. :OMCL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:OMCL) www.capitalcube.com - August 3 at 7:00 PM
	Omnicell Reaches Analyst Target Price (NASDAQ:OMCL) www.nasdaq.com - August 2 at 11:34 AM
	Omnicell Inc (NASDAQ:OMCL) Reported Q2 Financial Results - Street Report (NASDAQ:OMCL) www.streetreport.co - August 1 at 11:20 AM
	Omnicell Inc. (OMCL) Jumps 6.79% on July 29 - Equities.com (NASDAQ:OMCL) www.equities.com - July 30 at 6:00 PM
	Omnicell Inc. (OMCL) Jumps 6.79% on July 29 (NASDAQ:OMCL) www.equities.com - July 30 at 9:29 AM
	Omnicell Inc. (OMCL) Is Surging After Q2 Report (NASDAQ:OMCL) www.nasdaq.com - July 29 at 6:46 PM
	Edited Transcript of OMCL earnings conference call or presentation 28-Jul-16 8:30pm GMT (NASDAQ:OMCL) finance.yahoo.com - July 29 at 12:22 PM
	Omnicell Inc.: Omnicell Selected to Provide Interoperable Medication Automation Solutions to Support Patient Safety at Rochester Regional Health (NASDAQ:OMCL) www.twst.com - July 29 at 9:43 AM
	Omnicell reports 2Q loss (NASDAQ:OMCL) sg.finance.yahoo.com - July 28 at 5:55 PM
	Omnicell beats by $0.06, beats on revenue (NASDAQ:OMCL) seekingalpha.com - July 28 at 4:27 PM
	Q2 2016 Omnicell Inc Earnings Release - After Market Close (NASDAQ:OMCL) biz.yahoo.com - July 28 at 7:07 AM
	Medical Information Earnings on Jul 28: DRAD, OMCL, QSII (NASDAQ:OMCL) finance.yahoo.com - July 27 at 7:21 AM
	Can Shares Of Omnicell, Inc. (NASDAQ:OMCL) Hit $40? - Investor Newswire (NASDAQ:OMCL) www.investornewswire.com - July 26 at 6:56 PM
	Omnicell, Inc. (NASDAQ:OMCL) Updated Price Targets - FTSE News (NASDAQ:OMCL) www.ftsenews.co.uk - July 26 at 9:53 AM
	Will Omnicell, Inc. (NASDAQ:OMCL) Surprise Analysts? - Investor Newswire (NASDAQ:OMCL) www.investornewswire.com - July 24 at 6:08 PM
	Omnicell, Inc. (OMCL) Position Down in Latest Report from Conestoga Capital Advisors, LLC (NASDAQ:OMCL) www.fidaily.com - July 23 at 10:33 AM
	Omnicell, Inc. (NASDAQ:OMCL): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:OMCL) www.engelwooddaily.com - July 22 at 6:29 PM
	Omnicell Incorporated (NASDAQ:OMCL) Shorted Shares Increased By 6.5% - Consumer Eagle (NASDAQ:OMCL) www.consumereagle.com - July 22 at 6:29 PM
	Can Omnicell, Inc. (NASDAQ:OMCL) Surprise Analysts this Quarter? - Investor Newswire (NASDAQ:OMCL) www.investornewswire.com - July 22 at 6:29 PM
	Omnicell, Inc. (OMCL) Position Down in Latest Report from Conestoga Capital Advisors, LLC - Finance Daily (NASDAQ:OMCL) www.fidaily.com - July 22 at 6:29 PM
	Omnicell : to Release Second Quarter 2016 Earnings Results on July 28th (NASDAQ:OMCL) www.4-traders.com - July 22 at 9:37 AM
	Earnings Focus and Crowd Sourced Sentiment Review for Omnicell, Inc. (NASDAQ:OMCL) - TGP (NASDAQ:OMCL) telanaganapress.com - July 21 at 6:57 PM
	Omnicell : Henry Mayo Newhall Hospital Selects Omnicell Medication Automation to Improve Nursing Workflows and Patient Safety (NASDAQ:OMCL) www.4-traders.com - July 21 at 9:30 AM
	Omnicell to Release Second Quarter 2016 Earnings Results on July 28th (NASDAQ:OMCL) finance.yahoo.com - July 21 at 8:00 AM
	New System to Streamline Medication Management at Henry Mayo (NASDAQ:OMCL) scvnews.com - July 20 at 7:24 PM
	Henry Mayo Newhall Hospital Selects Omnicell Medication Automation to Improve Nursing Workflows and Patient Safety (NASDAQ:OMCL) finance.yahoo.com - July 20 at 8:00 AM
	Stock Positive on the Year: Omnicell, Inc. (NASDAQ:OMCL) - TGP (NASDAQ:OMCL) telanaganapress.com - July 19 at 7:53 AM
	Omnicell Inc Realized Volatility Hits Substantially Low Level - CML News (NASDAQ:OMCL) news.cmlviz.com - July 19 at 7:53 AM
	Medidata's Payment Solution to Make Reimbursements Easy (NASDAQ:OMCL) finance.yahoo.com - July 19 at 7:03 AM
	Share Performance Summary for: Omnicell, Inc. (NASDAQ:OMCL) - Press Telegraph (NASDAQ:OMCL) presstelegraph.com - July 18 at 6:47 PM